AAAAAA
Results:
1-9
|
Results: 9
Authors:
POLLAK PT
SLAYTER KL
Citation: Pt. Pollak et Kl. Slayter, CIPROFLOXACIN-PHENYTOIN INTERACTION - COMMENT, The Annals of pharmacotherapy, 31(12), 1997, pp. 1549-1550
Authors:
POLLAK PT
SLAYTER KL
Citation: Pt. Pollak et Kl. Slayter, HAZARDS OF DOUBLING PHENYTOIN DOSE IN THE FACE OF AN UNRECOGNIZED INTERACTION WITH CIPROFLOXACIN, The Annals of pharmacotherapy, 31(1), 1997, pp. 61-64
Authors:
POLLAK PT
SLAYTER KL
Citation: Pt. Pollak et Kl. Slayter, REDUCED SERUM THEOPHYLLINE CONCENTRATIONS AFTER DISCONTINUATION OF AZITHROMYCIN - EVIDENCE FOR AN UNUSUAL INTERACTION, Pharmacotherapy, 17(4), 1997, pp. 827-829
Authors:
MARRIE TJ
SLAYTER KL
Citation: Tj. Marrie et Kl. Slayter, NURSING HOME-ACQUIRED PNEUMONIA - TREATMENT OPTIONS, Drugs & aging, 8(5), 1996, pp. 338-348
Authors:
SLAYTER KL
PIERCE SM
MARRIE TJ
Citation: Kl. Slayter et al., POSSIBLE ZIDOVUDINE-ASSOCIATED HYPERSENSITIVITY, The Annals of pharmacotherapy, 30(10), 1996, pp. 1197-1197
Authors:
POLLAK PT
SLAYTER KL
Citation: Pt. Pollak et Kl. Slayter, DELIRIUM PROBABLY INDUCED BY CLARITHROMYCIN IN A PATIENT RECEIVING FLUOXETINE - REPLY, The Annals of pharmacotherapy, 30(10), 1996, pp. 1200-1200
Authors:
SLAYTER KL
LUDWIG EA
LEW KH
MIDDLETON E
FERRY JJ
JUSKO WJ
Citation: Kl. Slayter et al., ORAL-CONTRACEPTIVE EFFECTS ON METHYLPREDNISOLONE PHARMACOKINETICS ANDPHARMACODYNAMICS, Clinical pharmacology and therapeutics, 59(3), 1996, pp. 312-321
Authors:
SLAYTER KL
LUDWIG EA
LEW KH
MIDDLETON E
FERRY JJ
JUSKO WJ
Citation: Kl. Slayter et al., ORAL-CONTRACEPTIVE EFFECTS ON METHYLPREDNISOLONE PHARMACOKINETICS ANDPHARMACODYNAMICS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 182-182
Authors:
FOISY MM
SLAYTER KL
HEWITT RG
MORSE GD
Citation: Mm. Foisy et al., PANCREATITIS DURING INTRAVENOUS PENTAMIDINE THERAPY IN AN AIDS PATIENT WITH PRIOR EXPOSURE TO DIDANOSINE, The Annals of pharmacotherapy, 28(9), 1994, pp. 1025-1028
Risultati:
1-9
|